We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-9.64%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$585M
AUM Growth
-$73.1M
Cap. Flow
+$1.63M
Cap. Flow %
0.28%
Top 10 Hldgs %
31.26%
Holding
141
New
43
Increased
25
Reduced
14
Closed
51

Top Buys

Rank Stock Value
1
GRFS
Grifois
GRFS
+$10.6M
2
XENT
Intersect ENT, Inc
XENT
+$6.54M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.92M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$5.92M
5
ESTA icon
Establishment Labs
ESTA
+$5.5M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$10.1M
2
DHR icon
Danaher
DHR
+$7.15M
3
ARQL
Arqule Inc
ARQL
+$6.98M
4
GH icon
Guardant Health
GH
+$6.04M
5
ABBV icon
AbbVie
ABBV
+$5.82M

Sector Composition

Rank Sector Weight
1 Healthcare 39.74%
2 Industrials 1.15%
3 Consumer Staples 0.71%
4 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRKR icon
101
Bruker
BRKR
$8.69B
– –
-100,000
Closed -$5M
BSX icon
102
Boston Scientific
BSX
$74.2B
– –
-235,000
Closed -$10.1M
DHR icon
103
Danaher
DHR
$146B
– –
-56,400
Closed -$7.15M
GH icon
104
Guardant Health
GH
$22.2B
– –
-70,000
Closed -$6.04M
GH icon
105
PUT
Guardant Health
GH
$22.2B
– –
-142,200
Closed -$12.3M
GKOS icon
106
CALL
Glaukos
GKOS
$10.7B
– –
-65,000
Closed -$4.9M
GKOS icon
107
Glaukos
GKOS
$10.7B
– –
-30,000
Closed -$2.26M
GMED icon
108
PUT
Globus Medical
GMED
$11.4B
– –
-200,000
Closed -$8.46M
IART icon
109
Integra LifeSciences
IART
$1.35B
– –
-25,000
Closed -$1.4M
IHI icon
110
PUT
iShares US Medical Devices ETF
IHI
$3.47B
– –
-600,000
Closed -$24.1M
INCY icon
111
CALL
Incyte
INCY
$24.5B
– –
-100,000
Closed -$8.5M
INCY icon
112
Incyte
INCY
$24.5B
– –
-28,318
Closed -$2.41M
INGN icon
113
CALL
Inogen
INGN
$157M
– –
-50,000
Closed -$3.34M
IRTC icon
114
PUT
iRhythm Holdings
IRTC
$4.02B
– –
-100,000
Closed -$7.91M
LIVN icon
115
LivaNova
LIVN
$4.33B
– –
-30,000
Closed -$2.16M
LIVN icon
116
PUT
LivaNova
LIVN
$4.33B
– –
-40,000
Closed -$2.88M
MMSI icon
117
PUT
Merit Medical Systems
MMSI
$5.44B
– –
-100,000
Closed -$5.96M
MYGN icon
118
CALL
Myriad Genetics
MYGN
$308M
– –
-200,000
Closed -$5.56M
OFIX icon
119
Orthofix Medical
OFIX
$420M
– –
-93,794
Closed -$4.96M
OMCL icon
120
PUT
Omnicell
OMCL
$1.68B
– –
-50,000
Closed -$4.3M
PPH icon
121
PUT
VanEck Pharmaceutical ETF
PPH
$996M
– –
-100,000
Closed -$5.87M
PSNL icon
122
Personalis
PSNL
$1.5B
– –
-65,000
Closed -$1.76M
SPY icon
123
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$807B
– –
-150,000
Closed -$44M
SYK icon
124
CALL
Stryker
SYK
$134B
– –
-60,000
Closed -$12.3M
VTGN icon
125
VistaGen Therapeutics
VTGN
$11.9M
– –
-14,167
Closed -$308K
2 3 4
5
6

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2019 Portfolio in Review

As of Q3 2019, Pura Vida Investments held 141 positions worth $585M, down 11% from $658M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Pura Vida Investments's Q3 2019 filing shows 43 new, 25 increased, 14 reduced and 51 closed positions. Its largest new stake was Grifois: 496,201 shares worth $9.94M. The largest sale was Boston Scientific, an estimated $10.1M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 45% a quarter earlier, followed by Industrials and Consumer Staples.

  • Pura Vida Investments's largest Q3 2019 buy was Grifois: 496,201 shares worth $9.94M.
  • Pura Vida Investments added most to Intersect ENT, Inc in Q3 2019, an estimated $6.54M increase.
  • Pura Vida Investments's biggest Q3 2019 reduction was Zimmer Biomet, cutting an estimated $5.66M.
  • Pura Vida Investments fully exited Boston Scientific in Q3 2019, selling an estimated $10.1M.
  • Pura Vida Investments's ten largest holdings make up 31% of its $585M portfolio in Q3 2019.
  • Pura Vida Investments opened 43 new positions and closed 51 in Q3 2019.
  • Pura Vida Investments's portfolio value fell 11% quarter-over-quarter to $585M.

Based on Pura Vida Investments's 13F filing for Q3 2019, filed 14 Nov 2019.